articleThe LancetMar 8, 2012Closed access

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

TKTohru KobayashiTSTsutomu SajiTOTetsuya OtaniKTKazuo TakeuchiTNTetsuya Nakamura

Gunma University · Toho University · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

670
total citations
FWCI
38.06
Percentile
100%
References
34
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • Medicine
  • Prednisolone
  • Kawasaki disease
  • Internal medicine
  • Clinical endpoint
  • Aspirin
  • Adverse effect
  • Regimen
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.